National HIV/AIDS Strategy 2005-2008: Implementation Plan

5. A clearer direction for hiv/aids research

Page last updated: 07 November 2006

Priority Action Areas:

  • Establish consultative mechanisms and processes to set the agenda for the National Centres in HIV Research.
  • An annual roundtable consultation on research priorities for HIV/AIDS, STIs and hepatitis C. This will be facilitated by the MACASHH and will occur early each year to allow the roundtable to inform the National Centres' workplans.
  • Identify priority areas for the research agenda including ordering priority areas according to greatest need.

Responsibility:

Lead: Department of Health and Ageing; AFAO; NAPWA; AIVL; Scarlet Alliance.
Partners: States and Territories; National Centres in HIV/AIDS, Hepatitis C and STIs Research; ASHM; NHMRC; IGCAHRD.

By When:

Roundtable held annually
Other actions continuous.

Approach to Achieve Outcomes:

  • Identify priorities for research and advise on whether the National Centres' proposed workplans adequately address issues of strategic priority.
  • Ensure working groups are made up of representatives from all areas of the partnership as well as people with research expertise.
  • Consider mechanisms to engage the Scientific Advisory Committees of each National Centre.
  • Ensure interaction and collaboration with representation from target population groups when determining research priorities.
  • Integration of research funded by States and Territories with national research activities and priorities.
  • Negotiation with National Centres to ensure their workplans appropriately reflect strategic research priorities for HIV/AIDS.

Outcomes:

  • Annual Roundtables convened and research priorities identified.
  • National Centres' workplans reflect discussions on identified research priorities.
  • Comprehensive stakeholder involvement in the research roundtable and prioritisation of the research agenda.
  • States and Territories and national research activities and priorities integrated – in accordance with agreed strategic priorities.

Measures of Achievement:

  • Research Roundtable held annually, with comprehensive involvement of stakeholders.
  • Items on National Centres workplans completed (as appropriate) and contribute to policy development.

Priority Action Areas:

  • Maximising opportunities for HIV strategic research to devise better ways to use current therapies, and better options for side effects management.
  • Ongoing research into adherence strategies, treatment breaks and the role of treatments in the lives of PLWHA.

Responsibility:

Lead: Department of Health and Ageing (including TGA and PBAC); National Centres in HIV/AIDS, Hepatitis C and STIs Research; NAPWA Partners: ASHM; GP Organisations; MACASHH and Subcommittees; pharmaceutical industry; community based organisations.

By When:

Progressively

Approach to Achieve Outcomes:

  • Facilitate rapid and appropriate uptake of evidence-based therapies.
  • Include research on toxicity management.
  • Further investigate the use of genotypic resistance testing and its application for specific PLWHA populations.
  • Research addressing way to minimise possible negative impacts of treatment breaks through careful planning, education and monitoring of clinical outcomes.
  • Ensure research on issues of adherence, treatment breaks and the role of treatments in the lives of PLWHA is conducted and used to inform policy.
  • Ensure the research program continues to address emerging and agreed priority social and behavioural issues to provide an evidence-base for program development and adjustment.

Outcomes:

  • Relevant research conducted and this research is used to inform policy.
  • Evidence of appropriate uptake of evidence-based therapies.
  • Health and wellbeing of people living with HIV/AIDS optimised by new initiatives.
  • Minimise negative impacts of treatment breaks.
  • Increased research and consideration of clinical trials and programs to support side effects management of toxicities, side effects and adverse events for PLWHAs.

Measures of Achievement:

  • Relevant research published to enable it to be used to inform policy development.
  • Evidence of effective access for new diagnostic and monitoring tests, treatments and therapies.
  • Feedback to PLWHA describing reduced side effects from treatments.
  • Investigate the design and implementation of clinical trials and programs that deliver further data related to management of drug related events for HIV positive people.

Priority Action Area:

  • Consider ways to build capacity to analyse the economic costs and benefits to government and the community of HIV programs.

Responsibility:

Lead: Department of Health and Ageing.
Partners: States and Territories; National Centres in HIV/AIDS, Hepatitis C and STIs Research; AFAO; NAPWA; AIVL; Scarlet Alliance; IGCAHRD.

By When:

Completed by end of the life of the Strategy.

Approach to Achieve Outcomes:

  • Investigate and commission cost-benefit research for HIV programs including return on investment analysis.
  • All partners to evaluate their input to programs according to their capacity and ensure resources are appropriately directed.

Outcomes:

  • Research completed and published/distributed to all stakeholders in the partnership.

Measures of Achievement:

  • The costs and benefits to government and the community of HIV programs are reviewed and are measurable.

Priority Action Area:

  • Consider ways to create opportunities for increased interaction between the national centres, and between each of the national centres and researchers in Aboriginal and Torres Strait Islander health.

Responsibility:

Lead: Department of Health and Ageing.
Partners: National Centres in HIV/AIDS, Hepatitis C and STIs Research; Aboriginal and Torres Strait Islander researchers; NACCHO/ACCHOs
and affiliates.

By When:

Continuous

Approach to Achieve Outcomes:

  • Further develop the skills base among researchers and identify ways to engage Aboriginal and Torres Strait Islander researchers in community-related research.

Outcomes:

  • Evidence of increased interaction and collaboration eg regular meetings, increased research published with Aboriginal and Torres Strait
  • Islander researchers' partnership/input.
  • Increased research contributing directly (through collaboration or otherwise) to development of policy relating to reduction of HIV/AIDS, STIs and blood borne viruses in Aboriginal and Torres Strait Islander communities.

Measures of Achievement:

  • Number of interactions between the National Centres and researchers involved in Aboriginal and Torres Strait Islander health.
  • Evidence of collaboration of research between National Centres and researchers involved in Aboriginal and Torres Strait Islander health.

Priority Action Area:

  • Review of the criteria and constituencies of the Scientific Advisory Committees for the national centres.

Responsibility:

Lead: Department of Health and Ageing.
Partners: National Centres in HIV/AIDS, Hepatitis C and STIs Research.

By When:

June 2006

Approach to Achieve Outcomes:

  • The Department to consider, in partnership with the National Centres, the role of the SACs to better reflect the requirements of strategic research.